glp-1 and eating disorders disorder groups are sounding alarms about the rapid rollout of treatments, saying vulnerable people are being deliberately targeted by weight-loss marketing. The Australia New Zealand Academy for Eating GLP-1 for Weight Loss and

Prescriptions must be filled by 4/15/26

10.3390/ijms22073603 33 GabbyM.TauberM.PoratS.SimantovR

Histological and molecular aspects of oral squamous cell carcinoma (Review)

Active Malignancies (Cancer): Here's where things get incredibly nuanced, but the professional consensus leans heavily toward caution

What they're saying: "As the accessibility of these medications continues to rise and patient uptake increases, its crucial that we understand the neural mechanisms underlying the effects were seeing," Lorenzo Leggio, the clinical director of NIHs National Institute on Drug Abuse, said in a statement

More on sourcing below